France
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 26.70 B
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
2 |
USD 3.44 B
|
Dec. 31, 2023 | USD 5.49 | 1.56% |
|
France |
|
3 |
USD 3.44 B
|
Dec. 31, 2023 | USD 1.91 | 0.06% |
|
France |
|
4 |
USD 1.81 B
|
June 30, 2024 | USD 12.99 | 0.21% |
|
France |
|
5 |
USD 1.80 B
|
Dec. 31, 2023 | USD 122.64 | 0.35% |
|
France |
|
6 |
USD 1.20 B
|
Dec. 31, 2023 | USD 110.89 | -1.59% |
|
France |
|
7 |
USD 1.03 B
|
Dec. 31, 2023 | USD 208.18 | -0.28% |
|
France |
|
8 |
USD 561.70 M
|
Dec. 31, 2023 | USD 3.26 | 2.55% |
|
France |
|
9 |
USD 390.69 M
|
Dec. 31, 2023 | USD 23.70 | 2.39% |
|
France |
|
10 |
USD 356.60 M
|
Dec. 31, 2023 | USD 13.50 | -2.38% |
|
France |
|
11 |
USD 285.61 M
|
June 30, 2024 | USD 5.46 | 0.23% |
|
France |
|
12 |
USD 253.01 M
|
Dec. 31, 2023 | USD 27.36 | -1.07% |
|
France |
|
13 |
USD 232.47 M
|
June 30, 2024 | USD 23.39 | -1.14% |
|
France |
|
14 |
USD 175.35 M
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
15 |
USD 155.14 M
|
Dec. 31, 2023 | USD 1.74 | -2.29% |
|
France |
|
16 |
USD 153.85 M
|
Dec. 31, 2023 | USD 71.52 | -1.80% |
|
France |
|
17 |
USD 139.44 M
|
Dec. 31, 2023 | USD 27.83 | 2.50% |
|
France |
|
18 |
USD 119.35 M
|
Dec. 31, 2023 | USD 39.47 | -3.91% |
|
France |
|
19 |
USD 81.79 M
|
Dec. 31, 2023 | USD 10.08 | 4.45% |
|
France |
|
20 |
USD 77.31 M
|
Dec. 31, 2023 | USD 6.25 | -0.54% |
|
France |
|
21 |
USD 58.36 M
|
Dec. 31, 2023 | USD 26.07 | 0.60% |
|
France |
|
22 |
USD 55.36 M
|
Dec. 31, 2023 | USD 2.29 | 4.37% |
|
France |
|
23 |
USD 55.05 M
|
Dec. 31, 2023 | USD 3.05 | 0.95% |
|
France |
|
24 |
USD 50.44 M
|
June 30, 2024 | USD 3.36 | -0.01% |
|
France |
|
25 |
USD 45.06 M
|
Dec. 31, 2023 | USD 2.27 | 11.78% |
|
France |
|
26 |
USD 43.75 M
|
Dec. 31, 2023 | USD 1.88 | -0.49% |
|
France |
|
27 |
USD 42.47 M
|
Dec. 31, 2023 | USD 3.40 | -0.30% |
|
France |
|
28 |
USD 37.62 M
|
Dec. 31, 2023 | USD 0.68 | -1.49% |
|
France |
|
29 |
USD 37.34 M
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
30 |
USD 30.46 M
|
Dec. 31, 2023 | USD 2.02 | -2.42% |
|
France |
|
31 |
USD 23.70 M
|
Dec. 31, 2023 | USD 6.44 | -3.56% |
|
France |
|
32 |
USD 21.86 M
|
Dec. 31, 2023 | USD 6.08 | 1.81% |
|
France |
|
33 |
USD 20.75 M
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
34 |
USD 17.77 M
|
March 31, 2024 | USD 16.86 | 0.98% |
|
France |
|
35 |
USD 16.85 M
|
Dec. 31, 2023 | USD 1.82 | 1.18% |
|
France |
|
36 |
USD 16.83 M
|
Dec. 31, 2023 | USD 4.54 | 0.83% |
|
France |
|
37 |
USD 14.13 M
|
Dec. 31, 2023 | USD 20.08 K | 0.04% |
|
France |
|
38 |
USD 12.72 M
|
Dec. 31, 2023 | USD 8.53 | 3.61% |
|
France |
|
39 |
USD 11.07 M
|
Dec. 31, 2023 | USD 2.16 | 6.70% |
|
France |
|
40 |
USD 9.68 M
|
Dec. 31, 2023 | USD 1.50 | -9.33% |
|
France |
|
41 |
USD 9.29 M
|
Dec. 31, 2023 | USD 1.42 | -0.83% |
|
France |
|
42 |
USD 9.27 M
|
Dec. 31, 2023 | USD 3.97 | 0.60% |
|
France |
|
43 |
USD 9.03 M
|
Dec. 31, 2023 | USD 2.05 | -2.81% |
|
France |
|
44 |
USD 7.14 M
|
Dec. 31, 2023 | USD 2.22 | -0.32% |
|
France |
|
45 |
USD 4.87 M
|
Dec. 31, 2023 | USD 1.95 | -2.23% |
|
France |
|
46 |
USD 4.33 M
|
Dec. 31, 2023 | USD 1.29 | -1.75% |
|
France |
|
47 |
USD 4.10 M
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
|
48 |
USD 4.00 M
|
Dec. 31, 2023 | USD 1.94 | -0.97% |
|
France |
|
49 |
USD 2.54 M
|
Dec. 31, 2023 | USD 1.53 | 0.60% |
|
France |
|
50 |
USD 1.04 M
|
Dec. 31, 2023 | USD 4.25 | 1.59% |
|
France |
The Health Care company in France with the highest Current Liabilities is Sanofi (Paris Stock Exchange: SAN.PA) at USD 26.70 B.
The Health Care company in France with the lowest Current Liabilities is Predilife S.A. (Paris Stock Exchange: ALPRE.PA) at USD 1.04 M.
The top 10 Health Care companies in France by Current Liabilities are Sanofi, EMEIS, Clariane SE, Ramsay Générale de Santé SA, Ipsen S.A., bioMérieux S.A., Sartorius Stedim Biotech S.A., Euroapi S.A., LNA Santé SA and Cegedim SA.
The bottom 10 Health Care companies in France by Current Liabilities are Predilife S.A., Ikonisys S.A., NFL Biosciences SA, Neovacs S.A., ABIONYX Pharma SA, AFYREN SAS, Crossject Société Anonyme, Advicenne S.A., genOway Société anonyme and Affluent Medical SA.